Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
CORMEDIX INC
About CRMD
CorMedix Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases. The Company is focused on commercializing its lead product, DefenCath, which is an antimicrobial catheter lock solution approved to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure receiving chronic hemodialysis through a central venous catheter. DefenCath is a formulation of taurolidine 13.5 milligrams per milliliter (mg/mL), and heparin 1000 USP Units/mL indicated to reduce the incidence of catheter-related bloodstream infections (CRBSI) in adult patients with kidney failure receiving chronic hemodialysis through a central venous catheter (CVC). The Company is also commercializing a portfolio of anti-infective products including MINOCIN, REZZAYO, VABOMERE, ORBACTIV, BAXDELA, and KIMYRSA, as well as TOPROL-XL.
Find out what a historical investment in CORMEDIX INC would be worth today using our CRMD stock calculator.
Market Capitalisation
$592.31M
Price-earnings ratio
-
Dividend yield
0.00%
Volume
2.84M
High today
$8.21
Low today
$7.51
Open price
$7.95
52-week high
$17.43
52-week low
$6.13
Ready to start your investing journey with Stake?
Open an accountHow do I buy CRMD shares in Australia?
Buying CRMD shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in CORMEDIX INC in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in CRMD
What is the ticker symbol of CORMEDIX INC?
The ticker symbol for CORMEDIX INC is CRMD.
How much is one share of CRMD?
One share of CRMD is valued at $7.53 as of 16 May 2026.
What is the market capitalisation of CORMEDIX INC CRMD?
As of 16 May 2026 CORMEDIX INC has a market cap of $592.31M.
What is the P/E ratio of CRMD?
The Price to Earnings ratio of CRMD is 4.00.
What is the Earnings Per Share of CRMD?
The Earnings Per Share of CRMD is $1.98.
What is the 52-week high for CORMEDIX INC stock?
The CORMEDIX INC 52-week high stock price is $17.43.
What is the 52-week low for CORMEDIX INC stock?
The CORMEDIX INC 52-week low stock price is $6.13.
Can I buy CRMD shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy CRMD shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in CRMD on Stake
- Buy CRMD from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of CRMD from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
CRMD related stocks